Covered Call Analyzer from Investment Enhancing Systems, Inc.

Close Window

Buy 700 shares of RADIAN GROUP (RDN) at $7.10 (closing last trade price) and sell 7 call Out-of-the-Money contracts of RDN KB (Nov$10.00) at $0.45 (closing bid price) expiring on 11/21/2009. Cost is $4,990, and income from sale of the calls is $295 and includes your commissions. Annualized return if called is 468%.
Comments:	Exercised get-out price at $6.04 (-15%) on October 26 after buying back calls at $0.05. Final value including sale of all calls is $4,467, down (10.5%).
Buy 700 shares of PONIARD PHARMACEUTICALS (PARD) at $6.87 (closing last trade price) and sell 7 call Out-of-the-Money contracts of FQR KU (Nov$7.50) at $2.20 (closing bid price) expiring on 11/21/2009. Cost is $4,829, and income from sale of the calls is $1,520 and includes your commissions. Annualized return if called is 408%.
Comments:	Stock tanked on November 16 on bad news. Held till expiration and then sold all shares at $2.53 to close out position. Final value including sale of all calls is $3,290, down (31.9%).
Buy 400 shares of GTX INC (GTXI) at $10.26 (closing last trade price) and sell 4 call Out-of-the-Money contracts of GQH KV (Nov$12.50) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $4,124, and income from sale of the calls is $384 and includes your commissions. Annualized return if called is 310%.
Comments:	Stock tanked on November 2 on bad news. Held for five trading days and and then sold all shares at $2.53 on November 9 after biying bacl the calls at $0.05. Final value including sale of all calls is $2,172, down (47.3%).
Buy 400 shares of CADENCE PHARMACEUTICALS (CADX) at $10.55 (closing last trade price) and sell 4 call Out-of-the-Money contracts of QDC KV (Nov$12.50) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $4,240, and income from sale of the calls is $244 and includes your commissions. Annualized return if called is 240%.
Comments:	Exercised get-out price at $8.97 (-15%) on November 17 after buying back calls at $0.05. Final value including sale of all calls is $3,832, down (9.6%).
Buy 700 shares of MGIC INVESTMENTS CORP (MTG) at $6.42 (closing last trade price) and sell 7 call Out-of-the-Money contracts of MTG KU (Nov$7.50) at $0.35 (closing bid price) expiring on 11/21/2009. Cost is $4,514, and income from sale of the calls is $225 and includes your commissions. Annualized return if called is 216%.
Comments:	Exercised get-out price at $5.46 (-15%) on October 21 after buying back calls at $0.05. Final value including sale of all calls is $3,991, down (11.6%).
Buy 700 shares of RADIAN GROUP (RDN) at $7.10 (closing last trade price) and sell 7 call Out-of-the-Money contracts of RDN KU (Nov$7.50) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $4,990, and income from sale of the calls is $680 and includes your commissions. Annualized return if called is 191%.
Comments:	Exercised get-out price at $6.04 (-15%) on October 26 after buying back calls at $0.05. Final value including sale of all calls is $4,852, down (2.8%).
Buy 700 shares of LIZ CLAIBORNE INC (LIZ) at $7.05 (closing last trade price) and sell 7 call Out-of-the-Money contracts of LIZ KU (Nov$7.50) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $4,955, and income from sale of the calls is $435 and includes your commissions. Annualized return if called is 149%.
Comments:	Exercised get-out price at $5.99 (-15%) on October 28 after buying back calls at $0.05. Final value including sale of all calls is $4,572, down (7.7%).
Buy 500 shares of BIOCRYST PHARMACEUTICALS (BCRX) at $9.41 (closing last trade price) and sell 5 call Out-of-the-Money contracts of BIU KB (Nov$10.00) at $0.85 (closing bid price) expiring on 11/21/2009. Cost is $4,725, and income from sale of the calls is $408 and includes your commissions. Annualized return if called is 147%.
Comments:	Not called on November 21. Sold all shares at $9.55 to close out position on November 21. Final value including sale of all calls is $5,183, up 9.7%.
Buy 300 shares of UNIVERSAL TRAVEL GROUP (UTA) at $14.09 (closing last trade price) and sell 3 call Out-of-the-Money contracts of UTA KC (Nov$15.00) at $1.05 (closing bid price) expiring on 11/21/2009. Cost is $4,247, and income from sale of the calls is $301 and includes your commissions. Annualized return if called is 132%.
Comments:	Exercised get-out price at $11.98 (-15%) on October 30 after buying back calls at $0.05. Final value including sale of all calls is $3,865, down (9.0%).
Buy 500 shares of DEVELOPERS DIVERSIFIED (DDR) at $9.40 (closing last trade price) and sell 5 call Out-of-the-Money contracts of DDR KB (Nov$10.00) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $4,720, and income from sale of the calls is $308 and includes your commissions. Annualized return if called is 126%.
Comments:	Exercised get-out price at $7.99 (-15%) on November 4 after buying back calls at $0.05. Final value including sale of all calls is $4,260, down (9.7%).
Buy 400 shares of A-POWER ENERGY GENERATIO (APWR) at $11.74 (closing last trade price) and sell 4 call Out-of-the-Money contracts of UQR KV (Nov$12.50) at $0.75 (closing bid price) expiring on 11/21/2009. Cost is $4,716, and income from sale of the calls is $284 and includes your commissions. Annualized return if called is 122%.
Comments:	Exercised get-out price at $9.98 (-15%) on October 28 after buying back calls at $0.05. Final value including sale of all calls is $4,240, down (10.1%).
Buy 700 shares of ALLOS THERAPEUTICS INC. (ALTH) at $6.92 (closing last trade price) and sell 7 call Out-of-the-Money contracts of QAT KU (Nov$7.50) at $0.30 (closing bid price) expiring on 11/21/2009. Cost is $4,864, and income from sale of the calls is $190 and includes your commissions. Annualized return if called is 120%.
Comments:	Exercised get-out price at $5.88 (-15%) on October 30 after buying back calls at $0.05. Final value including sale of all calls is $4,250, down (12.6%).
Buy 800 shares of MATRIXX INITIATIVES INC (MTXX) at $5.56 (closing last trade price) and sell 8 call Out-of-the-Money contracts of IHU KU (Nov$7.50) at $0.25 (closing bid price) expiring on 11/21/2009. Cost is $4,468, and income from sale of the calls is $178 and includes your commissions. Annualized return if called is 388%.
Comments:	Exercised get-out price at $4.73 (-15%) on October 28 after buying back calls at $0.05. Final value including sale of all calls is $3,900, down (12.7%).
Buy 500 shares of BIOCRYST PHARMACEUTICALS (BCRX) at $9.41 (closing last trade price) and sell 5 call Out-of-the-Money contracts of BIU KV (Nov$12.50) at $0.40 (closing bid price) expiring on 11/21/2009. Cost is $4,725, and income from sale of the calls is $183 and includes your commissions. Annualized return if called is 367%.
Comments:	Not called on November 21. Sold all shares at $9.55 to close out position on November 21. Final value including sale of all calls is $4,957, up 4.9%.
Buy 800 shares of MELCO PBL ENTMNT LTD ADS (MPEL) at $6.06 (closing last trade price) and sell 8 call Out-of-the-Money contracts of NBQ KU (Nov$7.50) at $0.25 (closing bid price) expiring on 11/21/2009. Cost is $4,868, and income from sale of the calls is $178 and includes your commissions. Annualized return if called is 273%.
Comments:	Exercised get-out price at $5.15 (-15%) on October 27 after buying back calls at $0.05. Final value including sale of all calls is $4,236, down (13.0%).
Buy 600 shares of SINOVAC BIOTECH LTD (SVA) at $8.17 (closing last trade price) and sell 6 call Out-of-the-Money contracts of SVA KB (Nov$10.00) at $0.35 (closing bid price) expiring on 11/21/2009. Cost is $4,922, and income from sale of the calls is $191 and includes your commissions. Annualized return if called is 261%.
Comments:	Not called on November 21. Sold all shares at $7.55 to close out position on November 21. Final value including sale of all calls is $4,721, down (4.1%).
Buy 700 shares of GERON CORPORATION (GERN) at $6.50 (closing last trade price) and sell 7 call Out-of-the-Money contracts of GQD KU (Nov$7.50) at $0.25 (closing bid price) expiring on 11/21/2009. Cost is $4,570, and income from sale of the calls is $155 and includes your commissions. Annualized return if called is 185%.
Comments:	Exercised get-out price at $5.53 (-15%) on November 2 after buying back calls at $0.05. Final value including sale of all calls is $3,970, down (13.1%).
Buy 700 shares of WESTERN REFINING INC (WNR) at $6.66 (closing last trade price) and sell 7 call Out-of-the-Money contracts of WNR KU (Nov$7.50) at $0.25 (closing bid price) expiring on 11/21/2009. Cost is $4,682, and income from sale of the calls is $155 and includes your commissions. Annualized return if called is 157%.
Comments:	Exercised get-out price at $5.66 (-15%) on October 30 after buying back calls at $0.05. Final value including sale of all calls is $4,061, down (13.3%).
Buy 500 shares of HUNTSMAN CORP (HUN) at $9.01 (closing last trade price) and sell 5 call Out-of-the-Money contracts of HUN KB (Nov$10.00) at $0.35 (closing bid price) expiring on 11/21/2009. Cost is $4,525, and income from sale of the calls is $158 and includes your commissions. Annualized return if called is 142%.
Comments:	Not called on November 21. Sold all shares at $8.77 to close out position on November 21. Final value including sale of all calls is $4,542, up 0.4%.
Buy 700 shares of ENER1 INC (HEV) at $6.87 (closing last trade price) and sell 7 call Out-of-the-Money contracts of HEV KU (Nov$7.50) at $0.25 (closing bid price) expiring on 11/21/2009. Cost is $4,829, and income from sale of the calls is $155 and includes your commissions. Annualized return if called is 121%.
Comments:	Exercised get-out price at $5.84 (-15%) on October 26 after buying back calls at $0.05. Final value including sale of all calls is $4,187, down (13.3%).
Income from sale of calls is +$5,910
All positions closed out on November 21. Cost of these ten (20) stocks is $93,502 . At November 21, 2009 (expiration weekend), this list value is $83,551, down (10.6%).. The S&P500 was up 0.3% for the period this list was open.

*After the effect of all commissions.
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.